![Medical Health News](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/931/normal/Screen_Shot_2018-10-19_at_10.16.53.png?1539940643)
Sub-Group Analysis of Novocure's EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma ...
Medical Health News,
ST. HELIER, Jersey--( BUSINESS WIRE )--Novocure (NASDAQ:NVCR) announced today that the results of a retrospective post-hoc sub-gr…